Related Experiment Video

Updated: Jun 7, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

Factors associated with treatment lag in infantile spasms

Silvia Napuri, Edouard LE Gall, Olivier Dulac

    Developmental Medicine and Child Neurology
    |October 23, 2010
    PubMed

    Insights

    Delayed diagnosis of infantile spasms significantly impacts treatment outcomes. Improving early detection through practitioner training and parental awareness is crucial for better infant health.

    Area of Science:

    • Pediatric Neurology
    • Developmental Pediatrics
    • Epileptology

    Background:

    • Infantile spasms (IS) are a severe epilepsy syndrome in infants, often associated with developmental delay.
    • Early diagnosis and treatment are critical for improving neurodevelopmental outcomes in IS.
    • This study retrospectively analyzed diagnostic delays and their impact on IS management in Western France (1990-2003).

    Discussion:

    • Diagnostic delays for infantile spasms are common, with a mean time of 4 weeks from symptom onset to first medical visit.
    • Misdiagnosis is frequent, with gastro-oesophageal reflux being a common incorrect diagnosis.
    • Delays were significantly longer when initial consultations were with general practitioners compared to pediatricians.

    Key Insights:

    • A significant proportion of infants (38%) were misdiagnosed at their first visit, increasing to 74% after a second visit.
    • The time lag between symptom presentation and diagnosis was longer for infants seen by general practitioners (p=0.03).
    • Delayed diagnosis was associated with a poorer response to treatment.

    Outlook:

    • Training general practitioners on recognizing IS symptoms is essential to reduce diagnostic delays.
    • Educating parents of at-risk infants about IS can facilitate earlier presentation.
    • Routine electroencephalogram (EEG) before brain imaging in children with unexplained psychomotor delay is recommended to expedite diagnosis.
    Abstract

    More Related Videos

    Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy07:20

    Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

    Published on: August 9, 2024

    Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations05:04

    Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

    Published on: February 2, 2024

    Related Concept Videos

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

    Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

    Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
    SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
    Factors Affecting Drug Response: Overview01:21

    Factors Affecting Drug Response: Overview

    When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Spasmolytic Agents: Chemical Classification01:29

    Spasmolytic Agents: Chemical Classification

    Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
    A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also promote...
    Alterations in Muscle Tone ll01:12

    Alterations in Muscle Tone ll

    Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
    Antiepileptic Drugs: Glutamate Antagonists01:14

    Antiepileptic Drugs: Glutamate Antagonists

    Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...